655 related articles for article (PubMed ID: 34474013)
21. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.
Kuo CJ; Yang SY; Liao YT; Chen WJ; Lee WC; Shau WY; Chang YT; Tsai SY; Chen CC
Schizophr Bull; 2013 May; 39(3):648-57. PubMed ID: 22282455
[TBL] [Abstract][Full Text] [Related]
22. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder.
Canuso CM; Goldstein JM; Wojcik J; Dawson R; Brandman D; Klibanski A; Schildkraut JJ; Green AI
Psychiatry Res; 2002 Aug; 111(1):11-20. PubMed ID: 12140115
[TBL] [Abstract][Full Text] [Related]
23. Antipsychotic medications and sleep problems in patients with schizophrenia.
Cederlöf E; Holm M; Taipale H; Tiihonen J; Tanskanen A; Lähteenvuo M; Lahdensuo K; Kampman O; Wegelius A; Isometsä E; Kieseppä T; Palotie A; Suvisaari J; Paunio T;
Schizophr Res; 2024 May; 267():230-238. PubMed ID: 38579432
[TBL] [Abstract][Full Text] [Related]
24. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
[TBL] [Abstract][Full Text] [Related]
25. Quetiapine versus typical antipsychotic medications for schizophrenia.
Suttajit S; Srisurapanont M; Xia J; Suttajit S; Maneeton B; Maneeton N
Cochrane Database Syst Rev; 2013 May; (5):CD007815. PubMed ID: 23728667
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study.
Tiihonen J; Tanskanen A; Hoti F; Vattulainen P; Taipale H; Mehtälä J; Lähteenvuo M
Lancet Psychiatry; 2017 Jul; 4(7):547-553. PubMed ID: 28578901
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer risks following antipsychotic use in women with bipolar disorder versus schizophrenia: A territory-wide nested case-control study spanning two decades.
Chu RYK; Wei Y; Osborn DP; Ng VWS; Cheng FWT; Chan SKW; Chan SSM; Wong ICK; Chan EWY; Lai FTT
Psychiatry Res; 2023 Aug; 326():115287. PubMed ID: 37320990
[TBL] [Abstract][Full Text] [Related]
28. Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study.
De Hert M; Correll CU; Cohen D
Schizophr Res; 2010 Mar; 117(1):68-74. PubMed ID: 20060684
[TBL] [Abstract][Full Text] [Related]
29. The use of clozapine is protective for low bone mineral density induced by prolactin-raising antipsychotics in inpatients with schizophrenia.
Qiu J; Gong H; Wang B; Gu W; Wang L; Gu M; Zhang Y; Du X
Arch Osteoporos; 2020 Jun; 15(1):98. PubMed ID: 32601884
[TBL] [Abstract][Full Text] [Related]
30. Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs: An Observational Study of US Women (Ages 18-64 Years).
Rahman T; Sahrmann JM; Olsen MA; Nickel KB; Miller JP; Ma C; Grucza RA
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):7-16. PubMed ID: 34864772
[TBL] [Abstract][Full Text] [Related]
31. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
Ollendorf DA; Joyce AT; Rucker M
MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518
[TBL] [Abstract][Full Text] [Related]
32. Antipsychotic reexposure and recurrent pneumonia in schizophrenia: a nested case-control study.
Hung GC; Liu HC; Yang SY; Pan CH; Liao YT; Chen CC; Kuo CJ
J Clin Psychiatry; 2016 Jan; 77(1):60-6. PubMed ID: 26613551
[TBL] [Abstract][Full Text] [Related]
33. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
34. Clozapine and risperidone influence on cortisol and estradiol levels in male patients with schizophrenia.
Piriu G; Torac E; Gaman LE; Iosif L; Tivig IC; Delia C; Gilca M; Stoian I; Atanasiu V
J Med Life; 2015; 8(4):548-51. PubMed ID: 26664488
[TBL] [Abstract][Full Text] [Related]
35. [Prolactin, antipsychotics and breast cancer: is there a connection?].
Sabbe T; Detraux J; De Hert M
Tijdschr Psychiatr; 2016; 58(9):641-9. PubMed ID: 27639886
[TBL] [Abstract][Full Text] [Related]
36. Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia.
Lin CH; Lin CY; Wang HS; Lane HY
Sci Rep; 2019 Mar; 9(1):3895. PubMed ID: 30846868
[TBL] [Abstract][Full Text] [Related]
37. Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.
De Hert M; Peuskens J; Sabbe T; Mitchell AJ; Stubbs B; Neven P; Wildiers H; Detraux J
Acta Psychiatr Scand; 2016 Jan; 133(1):5-22. PubMed ID: 26114737
[TBL] [Abstract][Full Text] [Related]
38. The effects of atypical antipsychotics on serum prolactin levels.
Hamner M
Ann Clin Psychiatry; 2002 Sep; 14(3):163-73. PubMed ID: 12585566
[TBL] [Abstract][Full Text] [Related]
39. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.
Tiihonen J; Haukka J; Taylor M; Haddad PM; Patel MX; Korhonen P
Am J Psychiatry; 2011 Jun; 168(6):603-9. PubMed ID: 21362741
[TBL] [Abstract][Full Text] [Related]
40. Schizophrenia, antipsychotics and risk of hip fracture: a population-based analysis.
Sørensen HJ; Jensen SO; Nielsen J
Eur Neuropsychopharmacol; 2013 Aug; 23(8):872-8. PubMed ID: 23642346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
